Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Hammer

Showing results (31-40 of 92) with videos related to

Pageof 10
Sort By:
JAMA|February 15, 2001
Virologic and regimen termination surrogate end points in AIDS clinical trialsP B Gilbert, V DeGruttola, S M Hammer, et al.
Pharmacotherapy|January 1, 1987
Ganciclovir hepatotoxicityB F Shea, S Hoffman, G P Sesin, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1992
Didanosine and zidovudine resistance patterns in clinical isolates of human immunodeficiency virus type 1 as determined by a replication endpoint concentration assayG X McLeod, J M McGrath, E A Ladd, et al.
Nature Medicine|December 4, 2003
Antiretroviral treatment for HIV infection in developing countries: an attainable new paradigmJ P Moatti, I N'Doye, S M Hammer, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1982
Alpha interferon and acyclovir treatment of herpes simplex virus in lymphoid cell culturesS M Hammer, J C Kaplan, B R Lowe, et al.
The American Review of Respiratory Disease|July 1, 1985
Serologic diagnosis of focal pneumonia caused by Cryptococcus neoformansW A Jensen, R M Rose, S M Hammer, et al.
The American Journal of Medicine|July 1, 1990
Disseminated cryptococcosis diagnosed on peripheral blood smear in a patient with acquired immunodeficiency syndromeJ D Yao, C F Arkin, J P Doweiko, et al.
Medicine|September 1, 1994
Cytomegalovirus vasculitis. Case reports and review of the literatureM P Golden, S M Hammer, C A Wanke, et al.
The Journal of Infectious Diseases|July 1, 1991
Effect of the calcium channel blocker verapamil on human immunodeficiency virus type 1 replication in lymphoid cellsM A Harbison, S Y Kim, J M Gillis, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1986
In vitro modification of human immunodeficiency virus infection by granulocyte-macrophage colony-stimulating factor and gamma interferonS M Hammer, J M Gillis, J E Groopman, et al.
Pageof 10

Showing results (31-40 of 92) with videos related to

Sort By:
Pageof 10
JAMA|February 15, 2001
Virologic and regimen termination surrogate end points in AIDS clinical trialsP B Gilbert, V DeGruttola, S M Hammer, et al.
Pharmacotherapy|January 1, 1987
Ganciclovir hepatotoxicityB F Shea, S Hoffman, G P Sesin, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1992
Didanosine and zidovudine resistance patterns in clinical isolates of human immunodeficiency virus type 1 as determined by a replication endpoint concentration assayG X McLeod, J M McGrath, E A Ladd, et al.
Nature Medicine|December 4, 2003
Antiretroviral treatment for HIV infection in developing countries: an attainable new paradigmJ P Moatti, I N'Doye, S M Hammer, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1982
Alpha interferon and acyclovir treatment of herpes simplex virus in lymphoid cell culturesS M Hammer, J C Kaplan, B R Lowe, et al.
The American Review of Respiratory Disease|July 1, 1985
Serologic diagnosis of focal pneumonia caused by Cryptococcus neoformansW A Jensen, R M Rose, S M Hammer, et al.
The American Journal of Medicine|July 1, 1990
Disseminated cryptococcosis diagnosed on peripheral blood smear in a patient with acquired immunodeficiency syndromeJ D Yao, C F Arkin, J P Doweiko, et al.
Medicine|September 1, 1994
Cytomegalovirus vasculitis. Case reports and review of the literatureM P Golden, S M Hammer, C A Wanke, et al.
The Journal of Infectious Diseases|July 1, 1991
Effect of the calcium channel blocker verapamil on human immunodeficiency virus type 1 replication in lymphoid cellsM A Harbison, S Y Kim, J M Gillis, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1986
In vitro modification of human immunodeficiency virus infection by granulocyte-macrophage colony-stimulating factor and gamma interferonS M Hammer, J M Gillis, J E Groopman, et al.
Pageof 10